Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Assistance | 3 | 2021 | 33 | 1.120 |
Why?
|
| Mass Screening | 2 | 2023 | 1509 | 0.860 |
Why?
|
| Aftercare | 1 | 2023 | 259 | 0.790 |
Why?
|
| Food Supply | 2 | 2021 | 97 | 0.770 |
Why?
|
| Food Services | 1 | 2020 | 38 | 0.750 |
Why?
|
| BK Virus | 1 | 2021 | 123 | 0.730 |
Why?
|
| Cystitis | 1 | 2021 | 107 | 0.730 |
Why?
|
| Polyomavirus Infections | 1 | 2021 | 139 | 0.720 |
Why?
|
| Tumor Virus Infections | 1 | 2021 | 224 | 0.710 |
Why?
|
| Cytomegalovirus | 2 | 2023 | 482 | 0.700 |
Why?
|
| Homeless Youth | 1 | 2019 | 5 | 0.690 |
Why?
|
| Social Stigma | 1 | 2019 | 73 | 0.660 |
Why?
|
| Human Trafficking | 1 | 2019 | 38 | 0.650 |
Why?
|
| Health Policy | 1 | 2020 | 291 | 0.610 |
Why?
|
| Lung Transplantation | 1 | 2021 | 359 | 0.590 |
Why?
|
| Job Syndrome | 1 | 2016 | 19 | 0.580 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 548 | 0.550 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 6 | 2024 | 6550 | 0.550 |
Why?
|
| Heart Transplantation | 4 | 2023 | 908 | 0.510 |
Why?
|
| Influenza Vaccines | 3 | 2024 | 635 | 0.470 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2013 | 53 | 0.460 |
Why?
|
| Health Personnel | 1 | 2019 | 625 | 0.450 |
Why?
|
| Community-Acquired Infections | 2 | 2013 | 285 | 0.450 |
Why?
|
| Soft Tissue Infections | 1 | 2013 | 102 | 0.440 |
Why?
|
| Heart-Assist Devices | 4 | 2023 | 1171 | 0.420 |
Why?
|
| Influenza, Human | 3 | 2024 | 925 | 0.410 |
Why?
|
| Child | 23 | 2024 | 29154 | 0.410 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2024 | 242 | 0.410 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 308 | 0.370 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 1121 | 0.360 |
Why?
|
| Transplant Recipients | 4 | 2024 | 324 | 0.310 |
Why?
|
| Caregivers | 3 | 2023 | 677 | 0.310 |
Why?
|
| Clostridium Infections | 2 | 2022 | 252 | 0.300 |
Why?
|
| Leukocidins | 1 | 2006 | 46 | 0.280 |
Why?
|
| Exotoxins | 1 | 2006 | 77 | 0.270 |
Why?
|
| Endocarditis, Bacterial | 2 | 2018 | 128 | 0.270 |
Why?
|
| Ganciclovir | 2 | 2023 | 174 | 0.250 |
Why?
|
| Spleen | 2 | 2016 | 676 | 0.240 |
Why?
|
| Antibodies, Viral | 3 | 2024 | 1320 | 0.230 |
Why?
|
| Heart Failure | 3 | 2023 | 2516 | 0.230 |
Why?
|
| Osteomyelitis | 1 | 2006 | 236 | 0.220 |
Why?
|
| Texas | 3 | 2021 | 6311 | 0.220 |
Why?
|
| Immunogenicity, Vaccine | 3 | 2024 | 86 | 0.220 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2022 | 149 | 0.210 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2022 | 36 | 0.210 |
Why?
|
| Myelitis | 1 | 2022 | 26 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2023 | 147 | 0.200 |
Why?
|
| Enterovirus | 1 | 2022 | 63 | 0.200 |
Why?
|
| Pneumococcal Infections | 1 | 2023 | 241 | 0.200 |
Why?
|
| Enterovirus Infections | 1 | 2022 | 47 | 0.200 |
Why?
|
| Child, Preschool | 10 | 2024 | 16273 | 0.200 |
Why?
|
| Undocumented Immigrants | 1 | 2021 | 17 | 0.200 |
Why?
|
| Myositis | 1 | 2022 | 79 | 0.200 |
Why?
|
| Lymphopenia | 1 | 2023 | 199 | 0.200 |
Why?
|
| Humans | 30 | 2024 | 261506 | 0.190 |
Why?
|
| Child, Hospitalized | 1 | 2021 | 62 | 0.190 |
Why?
|
| Organ Transplantation | 1 | 2023 | 191 | 0.190 |
Why?
|
| Antiviral Agents | 3 | 2023 | 1230 | 0.190 |
Why?
|
| Meals | 1 | 2020 | 66 | 0.180 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 672 | 0.180 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2023 | 406 | 0.180 |
Why?
|
| Fear | 1 | 2021 | 254 | 0.180 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 222 | 0.170 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 462 | 0.170 |
Why?
|
| Retrospective Studies | 9 | 2023 | 37905 | 0.170 |
Why?
|
| Virus Diseases | 1 | 2023 | 398 | 0.170 |
Why?
|
| Neutropenia | 1 | 2023 | 968 | 0.170 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 167 | 0.170 |
Why?
|
| Schools | 1 | 2020 | 233 | 0.170 |
Why?
|
| Rural Population | 1 | 2020 | 281 | 0.160 |
Why?
|
| Single Photon Emission Computed Tomography Computed Tomography | 1 | 2018 | 37 | 0.160 |
Why?
|
| Medicaid | 1 | 2021 | 279 | 0.160 |
Why?
|
| Patient Discharge | 1 | 2023 | 661 | 0.160 |
Why?
|
| Overweight | 1 | 2021 | 484 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 761 | 0.150 |
Why?
|
| Hospitals | 1 | 2021 | 485 | 0.150 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 97 | 0.150 |
Why?
|
| Herpesvirus 4, Human | 2 | 2023 | 966 | 0.150 |
Why?
|
| Phosphotyrosine | 1 | 2016 | 111 | 0.140 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2016 | 51 | 0.140 |
Why?
|
| Adolescent | 7 | 2024 | 31252 | 0.140 |
Why?
|
| Half-Life | 1 | 2016 | 259 | 0.140 |
Why?
|
| Diterpenes | 1 | 2016 | 111 | 0.140 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2018 | 191 | 0.140 |
Why?
|
| Kidney Transplantation | 1 | 2022 | 755 | 0.140 |
Why?
|
| Prosthesis-Related Infections | 1 | 2018 | 232 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2016 | 234 | 0.130 |
Why?
|
| Protein Stability | 1 | 2016 | 370 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 598 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.130 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 1021 | 0.130 |
Why?
|
| Cough | 1 | 2016 | 116 | 0.130 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 698 | 0.130 |
Why?
|
| Stroke | 1 | 2023 | 1144 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2016 | 250 | 0.130 |
Why?
|
| Transposition of Great Vessels | 1 | 2015 | 124 | 0.120 |
Why?
|
| Parents | 1 | 2021 | 998 | 0.120 |
Why?
|
| Risk Factors | 3 | 2021 | 17523 | 0.120 |
Why?
|
| Recurrence | 3 | 2022 | 4758 | 0.120 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2013 | 128 | 0.120 |
Why?
|
| Eczema | 1 | 2013 | 37 | 0.120 |
Why?
|
| Smoking | 1 | 2023 | 2440 | 0.120 |
Why?
|
| Young Adult | 5 | 2023 | 21445 | 0.110 |
Why?
|
| Device Removal | 1 | 2015 | 337 | 0.110 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2024 | 152 | 0.110 |
Why?
|
| Students, Medical | 1 | 2018 | 399 | 0.110 |
Why?
|
| Infant | 4 | 2023 | 13310 | 0.110 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 1226 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.110 |
Why?
|
| Crohn Disease | 1 | 2016 | 351 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.110 |
Why?
|
| Diarrhea | 1 | 2016 | 686 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 1697 | 0.100 |
Why?
|
| Antibody Formation | 2 | 2024 | 383 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1732 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 499 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 1033 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 1323 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2015 | 846 | 0.090 |
Why?
|
| Protein Binding | 1 | 2016 | 3438 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2015 | 563 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 1586 | 0.080 |
Why?
|
| Female | 12 | 2022 | 141928 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 705 | 0.080 |
Why?
|
| Vaccines | 1 | 2023 | 389 | 0.080 |
Why?
|
| Cytokines | 1 | 2016 | 2809 | 0.080 |
Why?
|
| Male | 9 | 2021 | 123000 | 0.070 |
Why?
|
| United States | 2 | 2021 | 15433 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2023 | 32848 | 0.070 |
Why?
|
| Adhesins, Bacterial | 1 | 2006 | 85 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 147 | 0.070 |
Why?
|
| Lung | 1 | 2016 | 3151 | 0.060 |
Why?
|
| Bacterial Toxins | 1 | 2006 | 228 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2015 | 8223 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2019 | 5542 | 0.060 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2024 | 159 | 0.060 |
Why?
|
| Adult | 6 | 2023 | 77950 | 0.060 |
Why?
|
| Body Surface Area | 1 | 2023 | 42 | 0.060 |
Why?
|
| Vaccines, Conjugate | 1 | 2023 | 76 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 4821 | 0.060 |
Why?
|
| Vaccines, Inactivated | 1 | 2024 | 175 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2016 | 5270 | 0.050 |
Why?
|
| Pneumococcal Vaccines | 1 | 2023 | 161 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2023 | 380 | 0.050 |
Why?
|
| Thinness | 1 | 2021 | 82 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2023 | 556 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 709 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2002 | 134 | 0.050 |
Why?
|
| Acute Disease | 1 | 2006 | 2422 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 397 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2002 | 244 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 490 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 430 | 0.040 |
Why?
|
| Outpatients | 1 | 2022 | 462 | 0.040 |
Why?
|
| Age Factors | 2 | 2021 | 5377 | 0.040 |
Why?
|
| Body Weight | 1 | 2023 | 1293 | 0.040 |
Why?
|
| Feces | 1 | 2022 | 770 | 0.040 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2023 | 489 | 0.040 |
Why?
|
| Middle Aged | 3 | 2023 | 86204 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 4744 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2023 | 2588 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 471 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 748 | 0.040 |
Why?
|
| Mutation | 1 | 2016 | 15179 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2018 | 310 | 0.030 |
Why?
|
| Vaccination | 1 | 2002 | 1123 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 829 | 0.030 |
Why?
|
| Inpatients | 1 | 2021 | 678 | 0.030 |
Why?
|
| Animals | 3 | 2016 | 59536 | 0.030 |
Why?
|
| Infliximab | 1 | 2016 | 130 | 0.030 |
Why?
|
| Mice | 1 | 2016 | 34495 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 108 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 858 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 206 | 0.030 |
Why?
|
| Vomiting | 1 | 2016 | 354 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 783 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 2203 | 0.030 |
Why?
|
| Bioprosthesis | 1 | 2015 | 167 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 525 | 0.030 |
Why?
|
| Allografts | 1 | 2015 | 650 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 733 | 0.030 |
Why?
|
| Curriculum | 1 | 2018 | 860 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2015 | 412 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 1301 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2015 | 749 | 0.030 |
Why?
|
| Swine | 1 | 2015 | 1541 | 0.020 |
Why?
|
| Radiography | 1 | 2016 | 1904 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 4314 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 2015 | 386 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 1382 | 0.020 |
Why?
|
| Fatigue | 1 | 2016 | 1239 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2016 | 1863 | 0.020 |
Why?
|
| Obesity | 1 | 2021 | 2884 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 9244 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7573 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 12873 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5687 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6207 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10001 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 2992 | 0.010 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2002 | 6 | 0.010 |
Why?
|
| Ion Transport | 1 | 2002 | 79 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 2002 | 104 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 12926 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 159 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 842 | 0.010 |
Why?
|
| Communication | 1 | 2002 | 876 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 2803 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 6869 | 0.010 |
Why?
|